Dr. Caleb Knisley from University of South Carolina discusses a study at MDACC on the use of low dose naltrexone for refractory cancer pain. Malik A, Ye A, Chung M. Low Dose Naltrexone for Refractory Cancer Pain: Case Series of Initial Safety and Effectiveness. J Pain Symptom Manage. 2025;70(6):e492-e497. doi:10.1016/j.jpainsymman.2025.08.015 https://pubmed.ncbi.nlm.nih.gov/40849024/
December 2025
Click on the picture to view the YouTube recording